[Lactulose treatment in 80 cirrhotics: basic considerations and results].
D000328:Adult; D000641:Ammonia / Q000096:biosynthesis / Q000097:blood; D002855:Chromatography, Thin Layer; D004044:Dietary Proteins; D004187:Disaccharides / Q000008:administration & dosage / Q000627:therapeutic use*; D004926:Escherichia coli / Q000378:metabolism; D005243:Feces / Q000382:microbiology; D005260:Female; D005632:Fructose; D005690:Galactose; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007422:Intestines / Q000382:microbiology*; D007778:Lactobacillus / Q000378:metabolism; D007779:Lactobacillus acidophilus / Q000378:metabolism; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010636:Phenols / Q000096:biosynthesis; D011511:Proteus / Q000378:metabolism
D004044:Dietary Proteins; D004187:Disaccharides; D010636:Phenols; D005632:Fructose; D000641:Ammonia; D005690:Galactose
Lactulosetherapie bei 80 Leberzirrhosekranken: Grundlagen und Ergebnisse.